Meharry and pharma firms invest $80M in study of genetic variants in African-ancestry populations.
Meharry Medical College launched an initiative to study genetic variants affecting Black people with partners Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche.
Meharry Medical College launched an initiative to study genetic variants affecting Black people with partners Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche.
